Market Research Trends

The Biomedical Refrigerators and Freezers Market is expected to grow at a 5.9% CAGR during the forecast period, from US$ 3.2 billion in 2020 to US$ 6 billion by 2031. Biomedical refrigerators and freezers are medical devices that are used to keep biological samples such as biological reagents, blood, blood derivatives, medicines, vaccines, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and flammable chemicals cold. To effectively store biological samples, certain conditions must be met. Biomedical refrigerators and freezers, as opposed to domestic refrigerators and freezers, provide optimal conditions for the efficient storage of biological samples. Biomedical refrigerators and freezers are frequently used in blood banks, hospitals, diagnostic centres, research laboratories, educational institutions, and other facilities. Commercially available biomedical refrigerators and freezers can be used for a variety of applications based on temperature range. Ultra-low temperatur

In the forecast period of 2022 to 2032, the global DNA-based skin care market is expected to grow at a CAGR of 5.3%. It is projected to grow steadily, reaching $4.7 billion in 2022 and $8.2 billion in 2032. Rising consumer spending is expected to accelerate the beauty and personal care industry, driving sales of DNA-based skin care products. DNA-based skin care is the formulation and development of personalised skin care products based on patients' DNA. It entails obtaining DNA from a cheek swab and analysing it to determine the skin's inherent condition in terms of sun protection, collagen formation, antioxidant, glycation, and inflammation. Increased spending on health and wellness products, as well as ongoing advances in genomics, are expected to benefit the market. Another factor driving the market is the inherent desire to look young, particularly among the geriatric population. The growing influence of social media, lower prices for genetic diagnostics, and the exp

The global anti-viral drug market is expected to be worth $59,596.8 million in 2022. Throughout the forecast period, the introduction of generic antiviral medicines, as well as increased awareness about the availability of various vaccines for viral infections, are affecting growth. The overall demand for Anti-Viral Drugs is expected to grow at a CAGR of 3.9% between 2022 and 2032, reaching around US$ 87,675.36 Million. Anti-viral medications are medications that are used to treat viral infections. Unlike antibiotics, most anti-viral drugs are used to treat specific viral infections, whereas a broad-spectrum anti-viral drug is effective against a wide range of viruses. Antiviral drugs do not kill the pathogens they target; rather, they inhibit their growth. Because of increased awareness, an increase in diseased population, and the introduction of new drugs with improved efficacy, the global anti-viral drugs market is expected to grow at a moderate rate in the pharmaceutical marke

The global pressotherapy systems market was worth US$ 174.0 million in 2021 and is expected to expand at a 4.1% CAGR during the forecast period (2022 to 2032). The growing use of pressotherapy systems in medical spas and specialty clinics for lymphatic drainage massage and other functions is propelling pressotherapy system market sales. Diabetes and peripheral edoema are on the rise as a result of sedentary lifestyles and an ageing population. As a result, the use of lipo-laser and acoustic wave therapy is increasing, which is a major factor driving growth in the global pressotherapy systems market. Physical activity, particularly competitive activity, causes several negative changes in the human body. When muscle cells are damaged, chemicals like creatine kinase (CK), lactate dehydrogenase, and others are released, causing inflammation. Under these conditions, there is a decrease in performance, accelerated muscle ageing, a decrease in range of motion, and the onset of pain in

The global dentures market is expected to be worth US$ 1.7 billion by the end of 2022, rising at a 6.7% CAGR to around US$ 3.2 billion by 2032. According to a recent Future Market Insights analysis, complete dentures will command a 76.5% share of the global market in 2021. Dentures are an excellent treatment option for people who have partial or edentate dentition. Dentures are custom-made medical devices recommended by dentists and dental clinical specialists to replace oral soft and hard structures. According to an Adult Dental Health Survey, one in every five people in the UK wear dentures, and the prevalence of denture use increases with age. Denture bases can be made from acrylic (polymethylmethacrylate [PMMA]), metal alloys (cobalt-chromium), and polymers. Changing demographics indicate an increase in both life expectancy and the number of elderly people. Age-related population growth has increased the number of elderly people who require dentures. Complete dentures are one

The global wheelchairs market is expected to be worth US$ 5.7 billion by the end of 2022, rising at a 3.2% CAGR to US$ 7.9 billion by the end of 2032. Manual wheelchairs will account for approximately 70.5% of the global market in 2021, according to a recent study by Future Market Insights. Bringing together the skills and resources of the public, private, and nonprofit sectors is critical for fostering innovation and removing barriers to accessibility and affordability for assistive technology (AT). Access to an appropriate wheelchair is critical for people to become more economically and civically engaged while also avoiding negative health effects. A wheelchair is considered appropriate if it: meets the user's demands and environmental requirements; provides a proper fit with ergonomic adjustment; is safe and reliable; is widely available in the country; and can be obtained, maintained, and serviced in the country at a reasonable price. The use of a suitable wheelchair incr

In 2023, the global Lipid Nanoparticles market is expected to be worth US$ 887.2 million. With rising health concerns about dietary supplements as a result of Covid-19, and rising dietary supplement consumption, the overall demand for Lipid Nanoparticles is expected to grow at a CAGR of 13.6% between 2023 and 2033, reaching around US$ 3,175.5 million by 2033. Rapid population growth in regions such as Asia Pacific, Europe, and North America is expected to drive demand for products such as pharmaceuticals and healthcare, dietary supplements, functional food, functional beverages, cosmetics and personal care, and others. The high content of omega 3 and omega 6 in lipids is the primary reason for its widespread use in food and beverage products. Furthermore, rising global prices for fatty acids and other raw materials act as a global barrier to market growth. These price fluctuations are a result of the COVID-19 and the ongoing geopolitical conflict in Europe. The price of fatty acid

According to the newly released Hair Restoration industry analysis report from Future Market Insights, global sales of Hair Restoration in 2021 are expected to be US$ 4.9 billion. The projected market growth rate from 2022 to 2032 is 18.2%, which is significantly higher than the historical rate. With a CAGR of more than 19% between 2022 and 2032, Follicular Unit Extraction is expected to be the most profitable procedure type. Rising global disposable income, rising alopecia prevalence, and changing lifestyles among the global population are all driving market growth. This progression could be attributed to the increased success rate of hair transplantation surgeries, as well as technological advancements in the field of less invasive hair replacement. Excessive cigarette and alcohol consumption, as well as rising stress levels, have been identified as major triggers for the condition. Although the exact cause of the disease is unknown, hereditary factors have been linked to a few

The global hearing aids market is expected to grow at a 5.3% CAGR between 2022 and 2032. The market is expected to grow to $7.91 billion in 2022 and surpass a valuation of $13.27 billion by 2032. Different styles of hearing aids have different functionality. Hearing aid manufacturers strive to create the most inconspicuous hearing aid tools possible. Due to technological advancements, such hearing aid tools have shrunk in size while still delivering powerful sound. Hearing aid technology has advanced dramatically in recent years, thanks to the adoption of new component technology. People with various hearing disabilities have benefited from amplified high-quality systems. The system's common components include a microphone, a processor, a receiver, and a power source. The occurrence of such advancements in the hearing aid market improves the efficiency of these components while also making them more sustainable. A hearing aid tool or solution's function is to amplify the sou

From 2022 to 2032, the body contouring market is expected to grow at a 6.9% CAGR, rising from US$ 7.3 billion in 2022 to US$ 11.1 billion in valuation by 2032. Obesity cases in developed economies and around the world are expected to drive the global body contouring market. The increased safety and efficacy of these techniques, which improve the receiver's life expectancy and overall health, are expected to drive up demand for body contouring treatments. North America and Europe are the top two markets for body contouring devices due to high population growth, obesity prevalence, high demand for aesthetic surgery, and high consumption of junk food. According to a 2018 report by the American Society of Plastic Surgeons, 56,018 body contouring procedures were performed in the United States following massive weight loss. The same report covers 258,558 liposuction procedures performed in the United States, indicating a trend that could boost market growth in this region. Top Mar

With a 6.3% CAGR from 2022 to 2032, the global diabetes care devices market is expected to be worth US$ 9.7 billion in 2022 and US$ 17.87 billion by 2032. The diabetes care devices market is being driven by rising diabetes cases and increased use of insulin delivery devices. Changes in urbanisation, a growing preference for a fast-paced urban and sedentary lifestyle combined with an unhealthy diet, and an increase in diabetes cases have increased global sales of diabetes care devices. Furthermore, technological advancements in diabetes care devices drive market growth. Obesity, sedentary lifestyle, and poor diet, among other factors, are to blame for the rise in diabetics. Diabetes care device demand is expected to increase throughout the assessment period due to the rising prevalence of the disease and the high number of deaths - 6.7 million deaths in 2021 - caused by the disease. Key Takeaways: Market growth is being driven by an ageing population, laxer regulations,

The global Babesiosis Treatment market is expected to be worth $1.21 billion in 2023. With continuous advancements in babesiosis treatment drugs and biotechnology, the overall scope for the Babesiosis Treatment Market is expected to grow at a CAGR of 5.0% between 2023 and 2033, totaling approximately US$ 1.98 Billion by 2033. Due to factors such as the rising prevalence of babesiosis and lyme disease among individuals worldwide, the babesiosis treatment market is expected to grow significantly during the analysis period. Increased research efforts to develop an effective babesiosis treatment are also expected to drive market growth in the coming years. The International Lyme and Associated Disease Society (ILADS) reports that Lyme disease is frequently difficult to diagnose and treat, resulting in persistent infections and babesiosis disease. ILADS recommends tailored treatment based on the severity of symptoms, tick-borne coinfections, and the patient's response to treatment.

The global chronic odour and flavour loss treatment market is currently valued at $3146 million in 2023, with a 6.4% CAGR expected. The market is expected to reach $5850.2 million by 2033 as a result of technological advancements in healthcare. The chronic smell and flavour loss market is expected to be driven by rising cases of post-covid flavour loss over the forecast period. The ongoing COVID-19 crisis, as well as the expected success of the sole pipeline candidate, are expected to have an impact on the chronic smell and flavour loss treatment market in the coming years. The development of disease-specific therapies for chronic odour and flavour loss is encouraging for market growth. For example, phosphodiesterase (PDE) inhibitors designed for intranasal administration are present in CYR-064 compositions. The underlying mechanism of all pathologies causing smell and flavour loss is the same. It involves inhibiting the activation of stem cells, which is normally mediated by aden